Correlation Between Vertex Pharmaceuticals and IBEX Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and IBEX Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and IBEX Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals Incorporated and IBEX Technologies, you can compare the effects of market volatilities on Vertex Pharmaceuticals and IBEX Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of IBEX Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and IBEX Technologies.

Diversification Opportunities for Vertex Pharmaceuticals and IBEX Technologies

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Vertex and IBEX is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals Incorpo and IBEX Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IBEX Technologies and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals Incorporated are associated (or correlated) with IBEX Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IBEX Technologies has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and IBEX Technologies go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and IBEX Technologies

Assuming the 90 days horizon Vertex Pharmaceuticals Incorporated is expected to under-perform the IBEX Technologies. In addition to that, Vertex Pharmaceuticals is 1.58 times more volatile than IBEX Technologies. It trades about -0.05 of its total potential returns per unit of risk. IBEX Technologies is currently generating about 0.03 per unit of volatility. If you would invest  66,000  in IBEX Technologies on September 22, 2024 and sell it today you would earn a total of  2,400  from holding IBEX Technologies or generate 3.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.24%
ValuesDaily Returns

Vertex Pharmaceuticals Incorpo  vs.  IBEX Technologies

 Performance 
       Timeline  
Vertex Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vertex Pharmaceuticals Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
IBEX Technologies 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in IBEX Technologies are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, IBEX Technologies is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Vertex Pharmaceuticals and IBEX Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vertex Pharmaceuticals and IBEX Technologies

The main advantage of trading using opposite Vertex Pharmaceuticals and IBEX Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, IBEX Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IBEX Technologies will offset losses from the drop in IBEX Technologies' long position.
The idea behind Vertex Pharmaceuticals Incorporated and IBEX Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stocks Directory
Find actively traded stocks across global markets